Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Debra M Hunter

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
BMC Developmental Biology|January 4, 2011
Epithelial cell-directed efferocytosis in the post-partum mammary gland is necessary for tissue homeostasis and future lactationMelissa Sandahl, Debra M Hunter, Karen E Strunk, et al.
Cancer Immunology Research|July 8, 2024
MerTK Induces Dysfunctional Dendritic Cells by Metabolic ReprogrammingEden Y Zewdie, George M Edwards, Debra M Hunter, et al.
Cancer Research|July 20, 2007
HER4 D-box sequences regulate mitotic progression and degradation of the nuclear HER4 cleavage product s80HER4Karen E Strunk, Carty Husted, Leah C Miraglia, et al.
Molecular and Cellular Biology|July 15, 2009
ErbB4 splice variants Cyt1 and Cyt2 differ by 16 amino acids and exert opposing effects on the mammary epithelium in vivoRebecca S Muraoka-Cook, Melissa A Sandahl, Karen E Strunk, et al.
Cancer Immunology Research|August 28, 2019
TAM Family Receptor Kinase Inhibition Reverses MDSC-Mediated Suppression and Augments Anti-PD-1 Therapy in MelanomaAlisha Holtzhausen, William Harris, Eric Ubil, et al.
The Journal of Clinical Investigation|July 23, 2013
MerTK inhibition in tumor leukocytes decreases tumor growth and metastasisRebecca S Cook, Kristen M Jacobsen, Anne M Wofford, et al.
Molecular and Cellular Biology|August 18, 2006
Heregulin-dependent delay in mitotic progression requires HER4 and BRCA1Rebecca S Muraoka-Cook, Laura S Caskey, Melissa A Sandahl, et al.
Molecular Cancer Therapeutics|September 3, 2013
UNC569, a novel small-molecule mer inhibitor with efficacy against acute lymphoblastic leukemia in vitro and in vivoSandra Christoph, Deborah Deryckere, Jennifer Schlegel, et al.
Journal of Medicinal Chemistry|February 16, 2019
SGC-GAK-1: A Chemical Probe for Cyclin G Associated Kinase (GAK)Christopher R M Asquith, Benedict-Tilman Berger, Jing Wan, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
BMC Developmental Biology|January 4, 2011
Epithelial cell-directed efferocytosis in the post-partum mammary gland is necessary for tissue homeostasis and future lactationMelissa Sandahl, Debra M Hunter, Karen E Strunk, et al.
Cancer Immunology Research|July 8, 2024
MerTK Induces Dysfunctional Dendritic Cells by Metabolic ReprogrammingEden Y Zewdie, George M Edwards, Debra M Hunter, et al.
Cancer Research|July 20, 2007
HER4 D-box sequences regulate mitotic progression and degradation of the nuclear HER4 cleavage product s80HER4Karen E Strunk, Carty Husted, Leah C Miraglia, et al.
Molecular and Cellular Biology|July 15, 2009
ErbB4 splice variants Cyt1 and Cyt2 differ by 16 amino acids and exert opposing effects on the mammary epithelium in vivoRebecca S Muraoka-Cook, Melissa A Sandahl, Karen E Strunk, et al.
Cancer Immunology Research|August 28, 2019
TAM Family Receptor Kinase Inhibition Reverses MDSC-Mediated Suppression and Augments Anti-PD-1 Therapy in MelanomaAlisha Holtzhausen, William Harris, Eric Ubil, et al.
The Journal of Clinical Investigation|July 23, 2013
MerTK inhibition in tumor leukocytes decreases tumor growth and metastasisRebecca S Cook, Kristen M Jacobsen, Anne M Wofford, et al.
Molecular and Cellular Biology|August 18, 2006
Heregulin-dependent delay in mitotic progression requires HER4 and BRCA1Rebecca S Muraoka-Cook, Laura S Caskey, Melissa A Sandahl, et al.
Molecular Cancer Therapeutics|September 3, 2013
UNC569, a novel small-molecule mer inhibitor with efficacy against acute lymphoblastic leukemia in vitro and in vivoSandra Christoph, Deborah Deryckere, Jennifer Schlegel, et al.
Journal of Medicinal Chemistry|February 16, 2019
SGC-GAK-1: A Chemical Probe for Cyclin G Associated Kinase (GAK)Christopher R M Asquith, Benedict-Tilman Berger, Jing Wan, et al.
Pageof 1